Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Clinical Lymphoma & Myeloma|July 25, 2008
Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remissionJohn W Hayslip, Kit N SimpsonNutrition and Cancer|April 24, 2012
Immunonutrition: does it have a role in improving recovery in patients receiving a stem cell transplant?Adam D Lye, John W HayslipThe Oncologist|January 12, 2012
Shared decision making in oncology practice: what do oncologists need to know?Mary C Politi, Jamie L Studts, John W HayslipJournal of Psychosocial Oncology|July 4, 2012
Decision making and distress among individuals diagnosed with follicular lymphomaJennifer K Poe, John W Hayslip, Jamie L StudtsThe Lancet. Haematology|December 4, 2018
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 studyKieron Dunleavy, Michelle A Fanale, Jeremy S Abramson, et al.Pageof 1